This bill appropriates $1 million from the Medicaid Managed Care Excess Profit Fund for each of fiscal years 2025-26 and 2026-27 to the Nebraska Department of Health and Human Services. The funds are specifically designated for Program 33 to support the implementation of Legislative Bill 48 (which establishes Medicaid managed care reforms). The appropriation includes a $60,000 annual cap on salary and per diem expenses for the program. The bill becomes effective September 1, 2025, and directly affects Medicaid program administration.
This bill adds nurse anesthetists and dietitian nutritionists to Nebraska's Rural Health Systems and Professional Incentive Act. It expands eligibility for student loans and loan repayment programs to include these professions, allowing them to qualify for financial assistance if they practice in designated health shortage areas. Specifically, nurse anesthetists and dietitian nutritionists become eligible for up to $15,000 annually in loan repayment (capped at $45,000 total) under the same terms as other qualifying healthcare providers like nurse practitioners and physical therapists. The bill amends existing statutes to formally include these professions in program eligibility and shortage area designations.
This bill eliminates numerous state advisory groups, boards, and commissions - including the Climate Assessment Response Committee, Women's Health Initiative Advisory Council, and Palliative Care Act - and removes their funding. It also modifies department responsibilities, such as adjusting the Board of Mental Health Practice and the Department of Health and Human Services. The bill specifically terminates the Whiteclay Public Health Emergency Task Force and streamlines overlapping government structures by repealing obsolete provisions. These changes aim to simplify state agency operations by removing redundant entities and consolidating functions.
LB 319 adjusts Nebraska's eligibility rules for the Supplemental Nutrition Assistance Program (SNAP) by temporarily increasing the gross income threshold to 165% of the federal poverty guidelines (from the prior level) for qualifying residents. This change, effective until October 1, 2025, aims to expand access to SNAP benefits while maintaining work incentives - ensuring participants can keep benefits while seeking higher-paying jobs. The bill also requires the Department of Health and Human Services to develop a state outreach plan (partnering with nonprofits if needed), submit annual reports to the Legislature on program effectiveness, and evaluate administrative costs. It directly affects Nebraska residents seeking SNAP benefits, particularly those with incomes just above the previous threshold.
LB 326 amends Nebraska's insurance laws to update definitions and procedures under the Unfair Insurance Trade Practices Act and related statutes. It redefines key terms like "insurer" and "customer," changes the Director of Insurance's authority, and updates rules for claims, settlements, and annual reporting. The bill specifically eliminates the Health Insurance Access Act and Health Care Purchasing Pool Act, removing those frameworks from state law. These changes primarily affect insurance companies, consumers purchasing insurance, and the Nebraska Department of Insurance.
LB 457 requires Nebraska school districts and licensed child care facilities to adopt written policies for managing anaphylaxis (severe allergic reactions) by July 1, 2026. These policies must include emergency protocols, individualized care plans for children with allergies, and strategies to reduce allergen exposure, based on model guidelines developed by the Health and Human Services Department. The bill also limits out-of-pocket insurance costs for epinephrine injectors to $50 annually for covered individuals, effective January 1, 2026. It directly affects schools, child care programs, and insured individuals needing emergency allergy treatment.
Nebraska's LB 168 (signed April 9, 2025) adopts the 340B Contract Pharmacy Protection Act to protect access to federally discounted drugs. It prohibits drug manufacturers from restricting 340B drug deliveries to authorized locations (like contract pharmacies) or demanding extra data (such as patient records) beyond federal requirements. The law directly affects safety-net hospitals, clinics, and other 340B entities that rely on discounted drugs, as well as drug manufacturers and distributors. It ensures these providers can continue using 340B discounts without unnecessary barriers imposed by manufacturers.
